Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome : A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group

التفاصيل البيبلوغرافية
العنوان: Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome : A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group
المؤلفون: van de Loosdrecht, Arjan A., Kern, Wolfgang, Porwit, Anna, Valent, Peter, Kordasti, Sharham, Cremers, Eline, Alhan, Canan, Duetz, Carolien, Dunlop, Alan, Hobo, Willemijn, Preijers, Frank, Wagner-Ballon, Orianne, Chapuis, Nicolas, Fontenay, Michaela, Bettelheim, Peter, Eidenschink-Brodersen, Lisa, Font, Patricia, Johansson, Ulrika, Loken, Michael R., te Marvelde, Jeroen G., Matarraz, Sergio, Ogata, Kiyoyuki, Oelschlaegel, Uta, Orfao, Alberto, Psarra, Katherina, Subirá, Dolores, Wells, Denise A., Béné, Marie C., Della Porta, Matteo G., Burbury, Kate, Bellos, Frauke, van der Velden, Vincent H.J., Westers, Theresia M., Saft, Leonie, Ireland, Robin
المصدر: Cytometry Part B - Clinical Cytometry. 104(1):77-86
مصطلحات موضوعية: consensus, ELN, flow cytometry, myelodysplastic syndromes, standardization, Medicin och hälsovetenskap, Klinisk medicin, Hematologi, Medical and Health Sciences, Clinical Medicine, Hematology
الوصف: This article discusses the rationale for inclusion of flow cytometry (FCM) in the diagnostic investigation and evaluation of cytopenias of uncertain origin and suspected myelodysplastic syndromes (MDS) by the European LeukemiaNet international MDS Flow Working Group (ELN iMDS Flow WG). The WHO 2016 classification recognizes that FCM contributes to the diagnosis of MDS and may be useful for prognostication, prediction, and evaluation of response to therapy and follow-up of MDS patients.
URL الوصول: https://lup.lub.lu.se/record/7ccb7631-bb6a-4d92-91f1-85a098b89d51
http://dx.doi.org/10.1002/cyto.b.22044
قاعدة البيانات: SwePub
الوصف
تدمد:15524949
DOI:10.1002/cyto.b.22044